Recombinant F9 & F10 (Emicizumab Biosimilar) anticorps
Aperçu rapide pour Recombinant F9 & F10 (Emicizumab Biosimilar) anticorps (ABIN7795155)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Expression System
- Mammalian cells
-
Fonction
- Emicizumab Biosimilar, Human F10, F9 Monoclonal Antibody
-
Attributs du produit
- The anti-human F10, F9 monoclonal antibody emicizumab biosimilar was produced in mammalian cells.
-
Purification
- Protein A or G affinity column
-
Pureté
- >95 % by reducing SDS-PAGE
-
niveau d'endotoxine
- < 1 EU per 1 mg of the protein by the LAL method
-
Isotype
- IgG4, kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- > 3 mg/mL
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- F9 & F10 (Emicizumab Biosimilar)
-
Autre désignation
- Emicizumab Biosimilar
-
Classe de substances
- Biosimilar
Antigène
-